Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2014 2
2015 2
2016 3
2017 5
2018 2
2019 3
2020 3
2021 3
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Long-term incidence of haematological cancer after bariatric surgery or usual care in the Swedish Obese Subjects study: a prospective cohort study.
Sjöholm K, Andersson-Assarsson JC, Kristensson FM, Hjorth S, Garelius HG, Jacobson P, Svensson PA, Ahlin S, Carlsson B, Peltonen M, Carlsson LMS, Taube M. Sjöholm K, et al. Among authors: garelius hg. Lancet Healthy Longev. 2023 Oct;4(10):e544-e551. doi: 10.1016/S2666-7568(23)00141-1. Epub 2023 Sep 13. Lancet Healthy Longev. 2023. PMID: 37716360 Free article.
Inflammatory profile of lower risk myelodysplastic syndromes.
Topping J, Taylor A, Nadat F, Crouch S, Ibbotson A, Čermák J, Symeonidis A, Tatic A, Langemeijer S, Hellström-Lindberg E, Culligan D, Garelius HG, Ashcroft J, Nga E, Parker J, Kolade S, McDermott MF, De Witte T, Bowen D, Smith A, Cargo C, Savic S; ImmunAID consortium and EU‐MDS consortium. Topping J, et al. Among authors: garelius hg. Br J Haematol. 2024 May 21. doi: 10.1111/bjh.19530. Online ahead of print. Br J Haematol. 2024. PMID: 38772913
Therapy-related MDS dissected based on primary disease and treatment-a nationwide perspective.
Moreno Berggren D, Garelius H, Willner Hjelm P, Nilsson L, Rasmussen B, Weibull CE, Lambe M, Lehmann S, Hellström-Lindberg E, Jädersten M, Ejerblad E. Moreno Berggren D, et al. Among authors: garelius h. Leukemia. 2023 May;37(5):1103-1112. doi: 10.1038/s41375-023-01864-6. Epub 2023 Mar 17. Leukemia. 2023. PMID: 36928008 Free PMC article.
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.
Stojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R. Stojkov I, et al. Among authors: garelius h. Blood Adv. 2022 Jan 11;6(1):1-12. doi: 10.1182/bloodadvances.2021004568. Blood Adv. 2022. PMID: 34492684 Free PMC article.
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.
Hoeks M, Bagguley T, van Marrewijk C, Smith A, Bowen D, Culligan D, Kolade S, Symeonidis A, Garelius H, Spanoudakis M, Langemeijer S, Roelofs R, Wiegerinck E, Tatic A, Killick S, Panagiotidis P, Stanca O, Hellström-Lindberg E, Cermak J, van der Klauw M, Wouters H, van Kraaij M, Blijlevens N, Swinkels DW, de Witte T; EUMDS Registry Participants. Hoeks M, et al. Among authors: garelius h. Leukemia. 2021 Jun;35(6):1745-1750. doi: 10.1038/s41375-020-01022-2. Epub 2020 Sep 18. Leukemia. 2021. PMID: 32948844 Free PMC article. No abstract available.
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
Rasmussen B, Göhring G, Bernard E, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Öster Fernström A, Cavelier L, Papaemmanuil E, Ebeling F, Kittang AO, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E. Rasmussen B, et al. Among authors: garelius h. Leukemia. 2022 May;36(5):1436-1439. doi: 10.1038/s41375-022-01537-w. Epub 2022 Mar 11. Leukemia. 2022. PMID: 35277655 Free PMC article. Clinical Trial. No abstract available.
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C, Linde F, Hulegårdh E, Garelius H, Lazarevic V, Antunovic P, Cammenga J, Deneberg S, Eriksson A, Jädersten M, Björkvall CK, Möllgård L, Wennström L, Ölander E, Höglund M, Juliusson G, Lehmann S. Nilsson C, et al. Among authors: garelius h. Haematologica. 2023 Apr 1;108(4):1015-1025. doi: 10.3324/haematol.2022.281233. Haematologica. 2023. PMID: 36005563 Free PMC article.
Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden.
Juliusson G, Abrahamsson J, Lazarevic V, Antunovic P, Derolf Å, Garelius H, Lehmann S, Myhr-Eriksson K, Möllgård L, Uggla B, Wahlin A, Wennström L, Höglund M; Swedish AML Group and the Swedish Childhood Leukemia Group. Juliusson G, et al. Among authors: garelius h. Leukemia. 2017 Mar;31(3):728-731. doi: 10.1038/leu.2016.312. Epub 2016 Oct 31. Leukemia. 2017. PMID: 27795559 Free PMC article. No abstract available.
Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study.
Lindholm C, Olofsson E, Creignou M, Nilsson L, Garelius HG, Cammenga J, Ljungman P, Ejerblad E, Tobiasson M. Lindholm C, et al. Among authors: garelius hg. Bone Marrow Transplant. 2022 Apr;57(4):598-606. doi: 10.1038/s41409-022-01582-0. Epub 2022 Feb 2. Bone Marrow Transplant. 2022. PMID: 35105966 Free PMC article.
28 results